Drug intelligence / Profile preview

Wanhua Qianggu Plaster

Development stage: Unknown
Lead developer: Tonghua Wantong Pharmaceutical
Administration: Topical

Overview

Wanhua Qianggu Plaster is a topical Traditional Chinese Medicine (TCM) formulation developed by Tonghua Wantong Pharmaceutical for the treatment of frozen shoulder (scapulohumeral periarthritis). It is specifically indicated for patients presenting with the TCM syndrome of wind-cold-dampness obstruction, which is characterized by joint pain, stiffness, and restricted movement. The plaster is applied topically to the affected shoulder area to promote blood circulation, resolve blood stasis, and provide analgesic effects. In clinical development, it has been evaluated in Phase 3 trials in China, where its efficacy and safety were compared against oral Wanhua Qianggu Tablets in adults with painful frozen shoulder.

Brand names: Wanhua Qianggu Plaster
Other names: Wan Hua Qiang Gu Gao万花强骨膏

Beyond the preview

Go deeper on Wanhua Qianggu Plaster.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wanhua Qianggu Plaster.

Explore the full profile